Open Access Week: 22-28 October 2018, Globally!

Open Access Week is a global event held annually in October to raise awareness of the benefits of Open Access in the academic community. 

"Open Access refers to material that is free to all readers at the point of access, so they can use and share it easily" (OPEN ACCESS at Kent).

HowOpenIsIt- Open Access Guide (developed by SPARC) standardizes Open Access terminology in an easily understandable, comprehensive resource. 

Different countries, groups, communitis are joining forces for a new series of events dedicated to 2018 International Open Access Week Designing Equitable Foundations for Open Knowledge”. For example, OpenAIRE and FOSTER are delivering series of webinars and tutorials.

For more information about planned events and initiatives during International Open Access Week 2018, please visit www.openaccessweek.org and follow the conversation on Twitter at #OAWEEK !

From OPEN ACCESS to... Open Science & Open Data

Open Access Days 2018 – Part I: How is Open Access developing in the context of Open Science?

During the 22nd edition of the International Conference in ELectronic PUBlishing and the 10th anniversary of the meeting in Toronto, Canada, 22-24 June 2018, the Open Access conversation has been extended to Open Science and Open Data. The sustainability of Open Science infrastructures and ongoing community ownership and control of the Knowledge Commons were major themes at ELPUB 2018. The SCOSS initiative (SCOSS: A global Sustainability Coalition for Open Science Services) was introduced to participants, working towards guaranteeing financial sustainability for existing Open Science/Open Access initiatives, addressing the issue of financial sustainability.

Dr Aled Edwards – an expert scientist in structural biology (and pharmaceutical sciences) - delivered a keynote on Open Science for Public Good. Some key messages from his presentation on Open Science include:

Open Science: 

  • leads to competitive scientific outcomes and reproducible science;
  • helps build trust with the public and with patients;
  • reduces redundancy, which in turn accelerates research (which is good, since redundancy makes drug discovery less efficient – the drug price is high because it includes the price of failure and redundancy, which could have been avoided if science was open);
  • is a transparent way to recruit people (you can actually see people’s work!);
  • is sustainable - pharmaceuticals WILL fund open science. This isn’t going to lead them to a drug in the next 5 or 10 years, but it will enable research in other understudied areas. Open drug discovery may be the key to fixing the broken pharmaceutical model and to developing personalized medicines. All have to be collaborative about the funding structures. Governments always care about themselves, often thinking: “How do we make sure country X [us] wins and not country Y [them].” But open collaborations with industry enables academics to learn the market, spot commercial opportunities and launch companies. This should lead to benefit the country first of all;
  • is the solution, and should not just be the aim.

An example of an Open Science initiative shared by Dr Edwards: Extreme Open Science Initiative: A team of groundbreaking scientists at SGC, UNC and INSERM are now sharing their lab notebooks online.

Read more papers presented at the ELPUB2018 conference and benefit from the many messages and work done globally.

Related:

AIMS.FAO.ORG is looking forward towards creating awareness of the work done in Open AccessOpen Data, Open Science through dialogue, capacity development, collaboration and diversity, - in this way science can be advanced much faster, addressing the SDGs (Sustainable Development Goals).

To keep up-to-date with AIMS news, please, Sign up for AIMS News, follow @AIMS_Community on Twitter.

And, thanks again for your interest ! 


Add comment

Log in or register to post comments